SPOTLIGHT: Hospital investigating Baxter heparin deaths

Baxter has announced that providers at a hospital in Delaware, along with U.S. health officials, are looking into whether the deaths of two patients there were linked to a brand of Baxter's intravenous heparin product. The FDA has said the situation seems to be an isolated problem, but nobody's taking any chances. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.